Ordering RecommendationRecommendations when to order or not order the test. May include related or preferred tests.
Preferred test to follow-up presumptive results. For general screening, Cocaine, Urine with Reflex to Quantitation (2012231) is preferred.
MnemonicUnique test identifier.
CDCO COCA
MethodologyProcess(es) used to perform the test.
Quantitative Gas Chromatography-Mass Spectrometry
PerformedDays of the week the test is performed.
Sun-Sat
ReportedExpected turnaround time for a result, beginning when ARUP has received the specimen.
1-4 days
New York DOH Approval StatusIndicates test has been approved by the New York State Department of Health.
This test is New York DOH approved.
Specimen Required
Patient Preparation
Collect
Random urine.
Specimen Preparation
Transfer 3.5 mL urine with no additives or preservatives to an ARUP Standard Transport Tube. (Min: 1.5 mL)
Storage/Transport Temperature
Room temperature.
Unacceptable Conditions
Specimens exposed to repeated freeze/thaw cycles.
Remarks
Stability
Ambient: 1 week; Refrigerated: 1 month; Frozen: 3 years
Reference IntervalNormal range/expected value(s) for a specific disease state. May also include abnormal ranges.
Effective August 17, 2015
Drugs Covered
Cutoff Concentrations
Benzoylecgonine
50 ng/mL
Interpretive DataBackground information for test. May include disease information, patient result explanation, recommendations, details of testing, associated diseases, explanation of possible patient results.
Methodology: Quantitative Gas Chromatography-Mass Spectrometry
Positive cutoff: 50 ng/mL
For medical purposes only; not valid for forensic use.
The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory.
Compliance Statement B: For laboratory developed tests not using a RUO kit, and for FDA approved, cleared or 510(k) exempt assays with alterations. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
NoteAdditional information related to the test.
Hotline History
N/A
CPT CodesThe American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory are provided for informational purposes only. The codes reflect our interpretation of CPT coding requirements based upon AMA guidelines published annually. CPT codes are provided only as guidance to assist clients with billing. ARUP strongly recommends that clients confirm CPT codes with their Medicare administrative contractor, as requirements may differ. CPT coding is the sole responsibility of the billing party. ARUP Laboratories assumes no responsibility for billing errors due to reliance on the CPT codes published.
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
AliasesOther names that describe the test. Synonyms.
Benzoylecgonine
Benzoylmethylecgonine
Cocaine
Crack
Pain Management
Pain Management, Cocaine Metabolite with Confirmation with medMATCH, Urine
Pain Management, Cocaine Metabolite, Quantitative, with medMATCH, Urine
Chat
Feedback
